These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16013627)

  • 1. Predictors of referral for adjuvant therapy for colorectal cancer.
    Ong S; Watters JM; Grunfeld E; O'Rourke K
    Can J Surg; 2005 Jun; 48(3):225-9. PubMed ID: 16013627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004.
    Cree M; Tonita J; Turner D; Nugent Z; Alvi R; Barss R; King C; Winget M
    Clin Colorectal Cancer; 2009 Jul; 8(3):141-5. PubMed ID: 19632928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receipt of recommended therapy by patients with advanced colorectal cancer.
    Abraham NS; Gossey JT; Davila JA; Al-Oudat S; Kramer JK
    Am J Gastroenterol; 2006 Jun; 101(6):1320-8. PubMed ID: 16771956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Referral patterns and adjuvant chemotherapy use in patients with stage II colon cancer.
    Kirkpatrick HM; Aitelli CL; Qin H; Becerra C; Lichliter WE; McCollum AD
    Clin Colorectal Cancer; 2010 Jul; 9(3):150-6. PubMed ID: 20643619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
    Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
    J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer trends: surgical adjuvant therapy for colorectal cancer.
    Horsley JS
    Va Med; 1979 Nov; 106(11):836-9. PubMed ID: 506431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer.
    Cronin DP; Harlan LC; Potosky AL; Clegg LX; Stevens JL; Mooney MM
    Am J Gastroenterol; 2006 Oct; 101(10):2308-18. PubMed ID: 17032196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada.
    Eldin NS; Yasui Y; Scarfe A; Winget M
    Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):e9-17. PubMed ID: 21802914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer patterns of care in the Western Sydney and Wentworth Area Health Services.
    Barton MB; Gabriel GS; Miles S
    ANZ J Surg; 2004 Jun; 74(6):406-12. PubMed ID: 15191469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
    Keating NL; Landrum MB; Klabunde CN; Fletcher RH; Rogers SO; Doucette WR; Tisnado D; Clauser S; Kahn KL
    J Clin Oncol; 2008 May; 26(15):2532-7. PubMed ID: 18487570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does patient age still affect receipt of adjuvant therapy for colorectal cancer in New South Wales, Australia?
    Jorgensen ML; Young JM; Dobbins TA; Solomon MJ
    J Geriatr Oncol; 2014 Jul; 5(3):323-30. PubMed ID: 24656735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of postoperative adjuvant chemotherapy for colorectal cancer].
    Nozoe Y; Ogata Y; Miyagi Y; Nakagawa M; Matono K; Sasatomi T; Araki Y; Shirouzu K
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):67-72. PubMed ID: 11816480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patient's race/ethnicity does not explain the underuse of appropriate adjuvant therapy in colorectal cancer.
    McGory ML; Zingmond DS; Sekeris E; Bastani R; Ko CY
    Dis Colon Rectum; 2006 Mar; 49(3):319-29. PubMed ID: 16475031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does a rectal cancer of the upper third behave more like a colon or a rectal cancer?
    Rosenberg R; Maak M; Schuster T; Becker K; Friess H; Gertler R
    Dis Colon Rectum; 2010 May; 53(5):761-70. PubMed ID: 20389210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana.
    Wu X; Chen VW; Andrews PA; Chen L; Hsieh M; Fontham ET
    J La State Med Soc; 2004; 156(5):255-61. PubMed ID: 15554095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer.
    Earle CC; Weiser MR; Ter Veer A; Skibber JM; Wilson J; Rajput A; Wong YN; Benson AB; Shibata S; Romanus D; Niland J; Schrag D
    J Surg Oncol; 2009 Dec; 100(7):525-8. PubMed ID: 19697351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy for stage II colon cancer: influence of care structures' characteristics on a controversial clinical practice.
    Alter E; Phelip JM; Guilhot JN; Matysiak M; Vermorel M; Roblin X
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):995-1001. PubMed ID: 18049170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.